非传染性脑膜炎:使用生物药物进行治疗
S R Rathinam1, Somanath Anjana
1Uveitis Service, Aravind Eye Hospital and PG Institute of Ophthalmology, Madurai, Tamil Nadu, India.
Indian journal of ophthalmology
|March 12, 2026
概括
生物药物,如抗瘤缩因子α (TNF-α) 疗法,在皮质类固醇失效时,为非传染性脑膜炎提供有效的治疗. 这些先进疗法有助于控制炎症,并预防耐火病例患者的视力丧失.
科学领域:
- 眼科医生 眼科 眼科
- 免疫学 免疫学 免疫学
- 药理学 药理学是指药理学的学科.
背景情况:
- 尿道炎是视力丧失的重要原因,涉及眼睛中层的炎症.
- 皮质类固醇是非传染性脑膜炎的首要治疗方法,但对于耐火病例需要替代方案.
研究的目的:
- 审查生物制剂在管理非传染性紫外线炎中的作用和有效性.
- 以突出新兴的生物疗法,以治疗紫外线炎.
主要方法:
- 对非传染性紫外线炎的生物药物研究的文献综述.
- 对抗TNF-α药物和其他生物制剂的临床试验数据和病例报告的分析.
主要成果:
- 抗瘤坏死因子α (TNF-α) 药物,如阿达利木马布,在治疗非传染性脑膜炎方面是有效的.
- 其他生物药物,包括介质素和简氏激酶抑制剂,对脑膜炎的治疗有前途.
结论:
- 生物药物是非传染性紫外线炎患者的有价值的替代品,不能容忍或耐受常规疗法.
- 需要进一步的研究来证实生物治疗紫外线炎的长期安全性和有效性.
相关概念视频
Inflammatory Bowel Disease IV: Pharmacological Management
884
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Pharmacologic...
884
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
692
Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab...
692
Open Angle Glaucoma: Treatment
1.1K
In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
Drugs such as carbonic anhydrase inhibitors, α2- and...
1.1K
Myocarditis III: Medical Management
295
Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
295
Nephrotic Syndrome II : Assessment and Medical Management
293
IntroductionNephrotic syndrome is a kidney disorder marked by excessive protein loss in the urine, leading to various systemic complications. This condition often results from damage to the glomeruli—the kidney's filtering units—causing proteinuria, low blood protein levels, and fluid retention. Understanding the assessment, diagnosis, and management of nephrotic syndrome is essential for effective treatment and prevention of further kidney damage.AssessmentPatient History: Document...
293
Pericarditis III: Medical Management
469
The primary objectives of managing pericarditis are to determine the underlying cause, provide effective therapy for treatment and symptom relief, and promptly detect signs and symptoms of cardiac tamponade. The following outlines the essential aspects of medical management for pericarditis:ObjectivesDetermine the Cause: Identifying the underlying cause of pericarditis is crucial for targeted treatment. Causes include viral infections, autoimmune diseases, post-cardiac injury syndrome, and...
469


